1-1 of 1
Nick Doerr, PhD
Close
Save search
Sort by
Journal Articles

Results from a First-in-Human Study with Bnz-1: A Novel Peptide Inhibitor of IL-2, IL-9 and IL-15 for the Treatment of T-Cell Malignancies That Safely and Selectively Decreases Regulatory T-Cells, Natural Killer Cells, and CD8 + Central Memory T-Cells

Free
Paul Frohna, MD PhD PharmD, Yutaka Tagaya, MD PhD, Anoshie Ratnayake, MD, Nick Doerr, PhD, Asjad Basheer, PhD, Laith Al-Mawsawi, Woo Jae Kim, PhD, Juan Zapata, PhD, Xisorong Wu, BS, Nazli Azimi, PhD PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 695.
https://doi.org/10.1182/blood.V130.Suppl_1.695.695
Published: 2017